Literature DB >> 19895633

Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective.

Vijeya Ganesan1.   

Abstract

The paediatric neurologist is usually the clinician who makes the diagnosis of moyamoya in children, yet most of the debate in the literature has focused on surgical management of the condition. Semantic confusion and variable use of the term among neuroradiologists continues to be unhelpful. Increasing recognition of moyamoya, for example in sickle cell disease, and the publication of clinical guidelines encouraging referral for surgical evaluation highlight the need to identify and engage with management of the condition. In practical terms, the most frequent management issues for the paediatric neurologist, other than when to refer for surgery, are headache, hypertension, and the concern of the family that other children might be affected. These issues are discussed in the context of the available literature, and areas in which there is a need for research and consensus are identified.

Entities:  

Mesh:

Year:  2009        PMID: 19895633     DOI: 10.1111/j.1469-8749.2009.03527.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  9 in total

1.  Visualization and Classification of Deeply Seated Collateral Networks in Moyamoya Angiopathy with 7T MRI.

Authors:  T Matsushige; M Kraemer; T Sato; P Berlit; M Forsting; M E Ladd; R Jabbarli; U Sure; N Khan; M Schlamann; K H Wrede
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

2.  Efficacy of STA-MCA bypass surgery in moyamoya angiopathy: long-term follow-up of the Caucasian Krupp Hospital cohort with 81 procedures.

Authors:  Markus Kraemer; Rusen Karakaya; Toshinori Matsushige; Jonas Graf; Philipp Albrecht; Hans-Peter Hartung; Peter Berlit; Rudolf Laumer; Frank Diesner
Journal:  J Neurol       Date:  2018-08-28       Impact factor: 4.849

Review 3.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

4.  Moyamoya arteriopathy.

Authors:  Edward R Smith
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

5.  Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients.

Authors:  Markus Kraemer; Jan Claudius Schwitalla; Frank Diesner; Orhan Aktas; Hans-Peter Hartung; Peter Berlit
Journal:  J Neurol       Date:  2019-03-13       Impact factor: 4.849

Review 6.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 7.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

Review 8.  Hypertension and childhood stroke.

Authors:  Juan C Kupferman; Marc B Lande; Stella Stabouli; Dimitrios I Zafeiriou; Steven G Pavlakis
Journal:  Pediatr Nephrol       Date:  2020-04-29       Impact factor: 3.714

9.  The angiographic presentation of European Moyamoya angiopathy.

Authors:  Sara Pilgram-Pastor; René Chapot; Markus Kraemer
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.